Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Fluxion Launches High Throughput Quattro Array for BioFlux™

Published: Friday, October 18, 2013
Last Updated: Friday, October 18, 2013
Bookmark and Share
Quattro increases throughput 4X, enables HCS endpoint readout.

Fluxion Biosciences has announced that it has launched its BioFlux Quattro High Throughput Array System for physiologically relevant live cell analysis. The system is now commercially available and shipping to customers.

The Quattro Array system is sold as a separate component and can expand the capabilities of any existing BioFlux 200 or BioFlux 1000/1000z system. The Quattro Array runs up to 4 BioFlux plates at the same time.

Plates can be read by a microscope or High Content Screening system as a time-point or end-point assay. The increased throughput is especially valuable for lead optimization applications where the ability to closely simulate in vivo conditions is critical to identifying the best candidates for clinical development.

Introduced 5 years ago, the BioFlux system provides the ability to emulate physiological flow and shear forces in an in vitro model, while retaining the industry standard well plate format.

The system allows the execution of a multitude of assays requiring precise manipulation of the cellular micro-environment, including control of liquid composition, oxygen content, temperature, and shear.

Providing a much better approximation of in vivo conditions than traditional static well plate assays, BioFlux is becoming a standard in drug development and is used in many leading pharmaceutical companies such as Sanofi-Aventis, Actelion, Pfizer, Amgen, BMS, Merck, Bayer, Genentech, and many others.

“With the introduction of the BioFlux Quattro Array, we provide new and existing customers the ability to expand the throughput of their assays where physiologically-relevant conditions are required” said Jeff Jensen, CEO of Fluxion Biosciences.

Jensen continued, “Anti-platelet, anti-microbial, cancer, and anti-inflammatory drugs (to name a few) are examples of applications where drug response is affected by the environment around the cells. In these and many other drug applications, drug activity modulates, or is affected by, cellular responses caused by mechanical stress, dissolved gas concentration, or drug delivery profiles. With its unique capability to mimic conditions in the body, now at even higher throughput, the BioFlux system with the Quattro Array is a significant advance for drug development.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,900+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Fluxion Biosciences, UT Health Collaborate
Company has announced collaboration with UT Health to develop novel liquid biopsy approaches to improve the ability to diagnose, monitor, and treat cancer patients.
Saturday, April 30, 2016
Fluxion Biosciences to Distribute Millipore PrecisION® Ion Channel Cell Lines
Combination with IonFlux™ automated patch clamp system creates a validated, affordable solution for ion channel profiling and screening.
Thursday, December 22, 2011
Ohio State University Researchers Adopt IonFlux 16 Automated Patch Clamp System
First of kind high throughput instrument for research applications enables ion channel studies.
Monday, August 16, 2010
Scientific News
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
'Lab on the Skin' for Sweat Analysis
Northwestern University researchers develop a low-cost wearable electronic device that collects and analyzes sweat for health monitoring.
Toxoplasma’s Balancing Act Explained
Parasite’s method of rewiring our immune response leads to novel tool for drug tests.
Cancer Signaling Pathway Illuminating Way To Therapy
Researchers refine a pro-growth signalling pathway, common to cancers, that can kill cancer cells while leaving healthy cells unharmed.
Breast Cancer Cells Starve for Cystine
Depriving triple negative breast cancer, a treatment-resistant form of breast cancer, of cystine results in cancer cell death.
T Cell Channel Could Be Targeted to Treat Cancers
Researcher identify ion-channel found within T cells that could be targeted to reduce development of neck and head cancers.
Novel Urine Test to Predict High-Risk Cervical Cancer
Preliminary studies affirm accuracy and potential cost savings to screen for virus-caused malignancy.
Biomarker Guiding Cancer Therapy
Biologists link levels of Mena protein to breast cancer cells’ sensitivity to chemotherapy.
Protein Array Can Pinpoint Cancer Biomarker
A novel detection method for the detection of glycoproteins has been developed.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!